Work

1895MO Three-year follow-up results of the MERIT trial: A Japanese phase II study of nivolumab in malignant pleural mesothelioma

Year: 2020

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2020.08.1438

Authors: H. Hayashi, M. Okada, T. Kijima, K. Aoe, T. Kato, N. Fujimoto, K. Nakagawa, Y. Takeda, T. Hida, K. Kanai, J. Hirano, Y. Namba, Y. Ohe

Institutions: Kindai University, Hiroshima University, Hyogo Medical University, Kanagawa Cancer Center, Okayama Rosai Hospital, National Center for Global Health and Medicine, Aichi Cancer Center, Wakayama Medical University, Ono Pharmaceutical (Japan), National Cancer Center Hospital

Language: English

Topic: Occupational and environmental lung diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3088922385

FWCI: 0.348

Cites:

Cited by: 3

Related to: 10